DK363088A - Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler - Google Patents

Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler

Info

Publication number
DK363088A
DK363088A DK363088A DK363088A DK363088A DK 363088 A DK363088 A DK 363088A DK 363088 A DK363088 A DK 363088A DK 363088 A DK363088 A DK 363088A DK 363088 A DK363088 A DK 363088A
Authority
DK
Denmark
Prior art keywords
coats
double
strength
tumor cell
virus growth
Prior art date
Application number
DK363088A
Other languages
Danish (da)
English (en)
Other versions
DK363088D0 (da
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of DK363088D0 publication Critical patent/DK363088D0/da
Publication of DK363088A publication Critical patent/DK363088A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/922—Ribonucleases (RNAses); Deoxyribonucleases (DNAses)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK363088A 1987-07-17 1988-06-30 Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler DK363088A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7464987A 1987-07-17 1987-07-17

Publications (2)

Publication Number Publication Date
DK363088D0 DK363088D0 (da) 1988-06-30
DK363088A true DK363088A (da) 1989-01-18

Family

ID=22120800

Family Applications (1)

Application Number Title Priority Date Filing Date
DK363088A DK363088A (da) 1987-07-17 1988-06-30 Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler

Country Status (18)

Country Link
EP (2) EP0299745B1 (fi)
JP (1) JPH01104015A (fi)
KR (1) KR970007903B1 (fi)
CN (1) CN1032741A (fi)
AT (1) ATE123222T1 (fi)
AU (3) AU1820388A (fi)
CA (1) CA1331345C (fi)
DE (1) DE3853898T2 (fi)
DK (1) DK363088A (fi)
ES (1) ES2075835T3 (fi)
FI (1) FI883351A (fi)
GR (1) GR3017271T3 (fi)
IE (1) IE75896B1 (fi)
IL (1) IL86865A (fi)
NO (1) NO882854L (fi)
PT (1) PT87997B (fi)
RU (1) RU1838419C (fi)
ZA (1) ZA885095B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE72103B1 (en) * 1987-08-12 1997-03-12 Hem Res Inc Promotion of host defense by systemic dsRNA treatment
ATE122402T1 (de) * 1987-09-04 1995-05-15 Hem Pharma Corp Diagnose von mangelzuständen doppelsträngiger rns.
NO883868L (no) * 1987-09-04 1989-03-06 Hem Res Inc Fremgangsmaate for diagnostisering av dsrna-mangeltilstander, samt fremgangsmaate for fremstilling av preparater for diagnostisering og behandling av slike tilstander.
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
DE68914201T2 (de) * 1988-07-07 1994-07-14 Hem Pharma Corp Diagnose und Behandlung chronischer Ermüdungserscheinungen.
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
AU6740590A (en) * 1989-10-11 1991-05-16 Hem Research, Inc. Protection from shock subsequent to injury by double-stranded rnas
GB9108085D0 (en) * 1991-04-16 1991-06-05 Scras Complexes of polyadenylic acid with polyuridylic acid
CA2113573A1 (en) * 1991-07-16 1993-02-04 William Carter Modulation and diagnosis of cytokine dysfunctions
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
TW524693B (en) * 1997-10-16 2003-03-21 Nippon Shinyaku Co Ltd Cancer cell nuclease activator
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
CN100358534C (zh) * 2005-11-21 2008-01-02 北京百林康源生物技术有限责任公司 错位双链寡核苷酸在制备治疗禽流感病毒感染的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4024222A (en) 1973-10-30 1977-05-17 The Johns Hopkins University Nucleic acid complexes
DE3380200D1 (en) * 1982-09-16 1989-08-24 William Alvin Carter Anti-proliferative action of dsnras on tumor cells
CA1326450C (en) * 1985-08-26 1994-01-25 William A. Carter Modulation of aids virus-related events by double stranded rnas (dsrnas)

Also Published As

Publication number Publication date
ZA885095B (en) 1989-07-26
IL86865A (en) 1993-06-10
EP0525917A3 (en) 1993-02-24
PT87997B (pt) 1995-03-01
IE881895L (en) 1989-01-17
PT87997A (pt) 1989-06-30
AU1820388A (en) 1989-01-19
RU1838419C (ru) 1993-08-30
DE3853898D1 (de) 1995-07-06
FI883351A (fi) 1989-01-18
DK363088D0 (da) 1988-06-30
CA1331345C (en) 1994-08-09
KR970007903B1 (ko) 1997-05-17
KR890002420A (ko) 1989-04-10
FI883351A0 (fi) 1988-07-14
EP0299745A3 (en) 1989-12-06
ATE123222T1 (de) 1995-06-15
ES2075835T3 (es) 1995-10-16
IE75896B1 (en) 1997-09-24
NO882854D0 (no) 1988-06-28
EP0299745A2 (en) 1989-01-18
EP0299745B1 (en) 1995-05-31
JPH01104015A (ja) 1989-04-21
GR3017271T3 (en) 1995-11-30
CN1032741A (zh) 1989-05-10
IL86865A0 (en) 1988-11-30
NO882854L (no) 1989-01-18
EP0525917A2 (en) 1993-02-03
AU1502695A (en) 1995-07-06
DE3853898T2 (de) 1996-02-29
AU1619092A (en) 1992-08-13

Similar Documents

Publication Publication Date Title
Althaus et al. Effects of altered [ADP-ribose] n metabolism on expression of fetal functions by adult hepatocytes
DK363088A (da) Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler
Gribble et al. Collagen chain formation and peptidyl proline hydroxylation in monolayer tissue cultures of L-929 fibroblasts
ES2019727A6 (es) Un procedimiento para la preparacion de celulas de mamifero liofilizadas.
FI930206A0 (fi) Adoptiv immunoterapi med interleukin-7
DE3852714D1 (de) Oligodesoxynukleotide als Inhibitoren der Replikation von Retroviren und der Expression von Onkogenen.
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
ES8402346A1 (es) Procedimiento para la obtencion de lineas de celulas animales y humanas cultivables permanentemente.
BE842044A (fr) Composition polymerisant sous des conditions anaerobies et stable dans l'air
SE8501534D0 (sv) Interferon epsilon
ATE15693T1 (de) Zellkultur-verfahren.
ATE283921T1 (de) Zell- und/oder tumor-spezifische promotor- abhängige änderung der gezielten expression des herpes gamma 34.5 gens
ES8707565A1 (es) Un procedimiento para producir un anticuerpo monoclonal
GB1236596A (en) Semi-permeable membranes and acrylic copolymers for the production thereof
IT7827363A0 (it) Procedimento per produrre in parti di materia artificiale superfici insensibili all'uso.
JPS5639794A (en) Preparation of interferon
JPS5639795A (en) Preparation of interferon
WO1993013204A3 (de) Mittel zur stimulierung der teilungsaktivität tierischer zellen
HUT47747A (en) Method for correction defective ways of metabolism related to cycles of growth of spontaneous tomour-cells and viruses, with double-stranded rns
DK285587D0 (da) Ekspressionsvektor med evne til inducibar ekspression af et fremmed strukturgen, der baeres af ekspressionsvektoren, i vaertsceller og fremgangsmaade tilfremstilling af oenskede genprodukter
Burke-Gaffney et al. Assessment of Human Endothelial Permeability In Vitro: The Importance of Cell Seeding Density
STEIN Action of radiations on some biological model systems[Technical Progress Report, 1 Oct. 1975- 1 Jun. 1976]
IL84629A0 (en) Process and device for the cultivation of mammalian cells in a suspension culture,and their use for the preparation of proteins
Gasc et al. The Effects of Man of the Geographical Distribution of Amphibians and Lizards in the Guyano-Amazonian Area.).
Kaleta et al. Some metabolic and ionic responses during experimental immobilization(influence on basal metabolic rate)

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment